Mandate

Vinge adviser in the sale of SAGA Diagnostics

April 16, 2026 M&A

Vinge acted as legal adviser relating to Swedish law in connection with the sale of SAGA Diagnostics to Roche’s subsidiary Foundation Medicine.

Related

Vinge advises Latour on the sale of shares in ASSA ABLOY and Securitas, amounting to SEK 2.5 billion in each company

Vinge has advised Investmentaktiebolaget Latour (publ) in connection with the sale of parts of its shareholdings in ASSA ABLOY and Securitas for a total value of SEK 5 billion.
May 27, 2026

Vinge advises Hybridge Group on the acquisition of NESC

Hybridge Group and the consultancy firm NESC are merging. Through the merger, Hybridge Group is strengthening its offering in the field of prefabricated structural solutions.
May 27, 2026

Vinge advises Natur & Kultur in connection with the acquisition of Majema

Natur & Kultur has acquired 80 per cent of the shares in the educational publisher Majema. The acquisition is a strategic, long-term step in Natur & Kultur’s investment in educational materials.
May 27, 2026